Mechanism of isoflurane‑mediated breast cancer growth

breast cancer leukocyte function-associated antigen-1 volatile anesthetic

Journal

Oncology letters
ISSN: 1792-1082
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 15 12 2023
accepted: 23 02 2024
medline: 13 5 2024
pubmed: 13 5 2024
entrez: 13 5 2024
Statut: epublish

Résumé

Use of volatile anesthetics is associated with worse outcome following tumor resection surgery compared with the use of intravenous anesthetics. However, the underlying mechanism has not been clearly delineated yet

Identifiants

pubmed: 38736741
doi: 10.3892/ol.2024.14420
pii: OL-27-6-14420
pmc: PMC11083926
doi:

Types de publication

Journal Article

Langues

eng

Pagination

287

Informations de copyright

Copyright © 2024, Spandidos Publications.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Auteurs

Sophia Koutsogiannaki (S)

Department of Anesthesiology, Critical Care and Pain Medicine, Cardiac Anesthesia Division, Boston Children's Hospital, MA 02115, USA.
Department of Anaesthesia and Immunology, Harvard Medical School, Boston, MA 02115, USA.

Wei Wang (W)

Department of Anesthesiology, Critical Care and Pain Medicine, Cardiac Anesthesia Division, Boston Children's Hospital, MA 02115, USA.

Lifei Hou (L)

Department of Anesthesiology, Critical Care and Pain Medicine, Cardiac Anesthesia Division, Boston Children's Hospital, MA 02115, USA.
Department of Anaesthesia and Immunology, Harvard Medical School, Boston, MA 02115, USA.

Toshiaki Okuno (T)

Department of Biochemistry, Juntendo University Faculty of Medicine, Tokyo 113-8421, Japan.

Koichi Yuki (K)

Department of Anesthesiology, Critical Care and Pain Medicine, Cardiac Anesthesia Division, Boston Children's Hospital, MA 02115, USA.
Department of Anaesthesia and Immunology, Harvard Medical School, Boston, MA 02115, USA.

Classifications MeSH